Skip to main content

Table 7 Correlation between ribavirin dose reduction or discontinuation and relapse/non-response to treatment

From: Study the response of Qurevo (ombitasvir, paritaprevir, and ritonavir) in end-stage renal disease patients with hepatitis C virus

Relapses and non-response to treatment Ribavirin reduction or discontinuation Chi-square
Yes No Total
N % N % N % X2 P-value
No relapse, no non-response 4 100.00 42 91.30 46 92.00 0.378 0.828
Relapse 0 0.00 2 4.35 2 4.00
Non-response to ttt 0 0.00 2 4.35 2 4.00
Total 4 100.00 46 100.00 50 100.00